aspirin has been researched along with Abortion, Recurrent in 236 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts." | 9.14 | Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. ( Barrett, J; Clark, CA; Crowther, MR; Gent, M; Ginsberg, JS; Hawker, GA; Kingdom, JC; Laskin, CA; Spitzer, KA, 2009) |
| "To assess whether treatment with enoxaparin and low-dose aspirin, along with intensive pregnancy surveillance, reduces rate of pregnancy loss compared with intensive pregnancy surveillance alone in women with history of 2 or more consecutive previous pregnancy losses, a parallel group, multicenter, randomized controlled trial was performed in the United Kingdom and New Zealand." | 9.14 | SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. ( Clark, P; Crichton, L; Greaves, M; Greer, IA; Langhorne, P; Thomson, A; Walker, ID; Whyte, S, 2010) |
| "Aspirin combined with LMWH for APS may improve live birth rate, and detection of d-dimer levels in APS pregnant women may predict pregnancy complications and guide the use of anticoagulants." | 9.12 | Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels. ( Diao, QZ; Gu, ZD; Shi, T, 2021) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 9.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "In patients with aPL syndrome, IVIG treatment improved pregnancy outcome, with significantly lower pregnancy complication rates, when compared with prednisone plus LDA therapy." | 9.09 | Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. ( Cesa, F; Di Pierro, G; Lazzarin, N; Menghini, S; Romanini, C; Valensise, H; Vaquero, E, 2001) |
| "This study was conducted to determine if lower dose heparin (LD Heparin) combined with aspirin is as efficacious as higher dose heparin (HD Heparin) for the treatment of the antiphospholipid antibody syndrome in women seeking pregnancy." | 9.08 | A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. ( Ermel, LD; Kutteh, WH, 1996) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 9.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL)." | 9.05 | Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. ( Goddijn, M; Hamulyák, EN; Marijnen, MC; Middeldorp, S; Scheres, LJ, 2020) |
| "An improvement of pregnancy outcomes in women with RSA and APS can be achieved by treatment strategies combining low-dose aspirin plus heparin or heparin alone." | 9.01 | Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. ( Jiang, HL; Liu, Y; Lu, C, 2019) |
| "To determine in women with hereditary thrombophilia whether the use of the combination of low-molecular-weight heparin (LMWH) and aspirin (ASA) is better than ASA alone." | 8.93 | Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. ( Areia, AL; Areia, M; Fonseca, E; Moura, P, 2016) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 8.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 8.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia." | 8.85 | Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. ( Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2009) |
| "To assess the clinical efficacy of intravenous immunoglobulin G (IVIG) administration combined with low-dose aspirin in women with unexplained recurrent pregnancy loss (RPL)." | 8.12 | Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. ( Chae, HD; Kim, JH; Kim, SH; Ko, Y; Lee, SR; Yang, N, 2022) |
| "In this post hoc study, arachidonic acid (AA)-induced platelet aggregation during pregnancy with and without acetylsalicylic acid (ASA) treatment was studied in 323 women with unexplained recurrent first-trimester miscarriage and in 59 healthy women with normal pregnancies." | 8.12 | Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study. ( Blomqvist, LRF; Hellgren, MSE; Jeppsson, A; Strandell, AM, 2022) |
| "To assess the differences in Doppler parameters of endometrial receptivity in unexplained recurrent biochemical pregnancy loss (URBPL) and the therapeutic effect of low-dose aspirin (LDA)." | 8.12 | Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss. ( Bai, W; Guo, F; Wang, Q; Zhang, X; Zhao, A, 2022) |
| "To investigate the therapeutic role of prednisone in patients having unexplained recurrent pregnancy loss (URPL) with positivity of antinuclear antibodies (ANA) and the relationship between ANA titers, prednisone, and pregnancy outcomes." | 8.02 | Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss. ( Chen, C; Guo, F; Kou, X; Li, C; Sun, S; Zhao, A, 2021) |
| "To evaluate differences in Doppler parameters and pregnancy outcomes, if any, and to determine the predictive accuracy of such indices, as well as the effects of low-dose aspirin (LDA) in unexplained recurrent pregnancy loss (URPL)." | 7.96 | Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss. ( He, L; Kang, X; Liu, F; Liu, Z; Wang, T; Zhao, A, 2020) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 7.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss." | 7.74 | Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. ( Kumagai, K; Nakanishi, T; Ozaki, Y; Sato, T; Sugiura-Ogasawara, M; Suzumori, N, 2008) |
| "Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome." | 7.73 | Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. ( Black, S; Bose, P; Huppertz, B; Kadyrov, M; Neulen, J; Regan, L; Weissenborn, U, 2005) |
| "The use of prophylactic treatments against thrombophilia becomes necessary in order to increase the live birth rates in women with RPL." | 5.56 | Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages? ( Aslan, I; Ozyigit, S; Paul, LT; Tosun, O; Tulay, P, 2020) |
| " The evidence demonstrates that the treatments to consider are first-trimester progesterone administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspirin and heparin in women with antiphospholipid antibodies." | 5.41 | Interventions to prevent miscarriage. ( Coomarasamy, A; Devall, A; Dhillon-Smith, RK; Fox, E; Kaur, R; Melo, P; Woodhead, N, 2023) |
| "Women with inherited thrombophilia and recurrent miscarriage might benefit from preconceptional antiagreggation with low-dose acetylsalicylic acid (ASA), but concerns about severe adverse reactions may prevent physicians from performing this treatment in patients with ASA hypersensitivity." | 5.38 | Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage. ( Gaspar, A; Livramento, S; Morais-Almeida, M; Sampaio, G; Santos, N, 2012) |
| "Screening results for thrombophilia and antithrombotic treatment with enoxaparin, aspirin, or both and pregnancy outcomes." | 5.27 | The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages. ( Elias, A; Elias, M; Nahas, R; Saliba, W, 2018) |
| "LMWH and LMWH combined with aspirin therapy cannot improve the pregnancy outcome of women with uRM and negative aPL." | 5.22 | Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial. ( Li, H; Wang, D; Yan, P; Yan, X, 2022) |
| "To determine whether low molecular weight heparin (LMWH) plus low-dose aspirin (LDA) is comparable in efficacy and safety to unfractionated heparin (UFH) plus LDA in the management of pregnant women with a history of recurrent spontaneous abortion secondary to antiphospholipid syndrome (APS)." | 5.15 | Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. ( Abdou, AM; Fouda, IM; Fouda, UM; Ramadan, DI; Sayed, AM; Zaki, MM, 2011) |
| "To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts." | 5.14 | Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. ( Barrett, J; Clark, CA; Crowther, MR; Gent, M; Ginsberg, JS; Hawker, GA; Kingdom, JC; Laskin, CA; Spitzer, KA, 2009) |
| "To assess whether treatment with enoxaparin and low-dose aspirin, along with intensive pregnancy surveillance, reduces rate of pregnancy loss compared with intensive pregnancy surveillance alone in women with history of 2 or more consecutive previous pregnancy losses, a parallel group, multicenter, randomized controlled trial was performed in the United Kingdom and New Zealand." | 5.14 | SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. ( Clark, P; Crichton, L; Greaves, M; Greer, IA; Langhorne, P; Thomson, A; Walker, ID; Whyte, S, 2010) |
| " We then randomly assigned them to receive daily 80 mg of aspirin plus open-label subcutaneous nadroparin (at a dose of 2850 IU, starting as soon as a viable pregnancy was demonstrated), 80 mg of aspirin alone, or placebo." | 5.14 | Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. ( Büller, HR; Folkeringa, N; Goddijn, M; Hamulyák, K; Hutten, BA; Kaandorp, SP; Middeldorp, S; Mol, BW; Nahuis, M; Papatsonis, DN; van der Post, JA; van der Veen, F; Verhoeve, HR, 2010) |
| "To compare the use of enoxaparin alone with combination therapy of prednisone, aspirin and progesterone in the treatment of women with idiopathic recurrent miscarriage (IRM) in terms of live births and pregnancy outcome." | 5.13 | Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. ( El-Refaiey, AA; El-Tatongy, M; Fawzy, M; Mosbah, A; Shokeir, T; Warda, O, 2008) |
| "Aspirin combined with LMWH for APS may improve live birth rate, and detection of d-dimer levels in APS pregnant women may predict pregnancy complications and guide the use of anticoagulants." | 5.12 | Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels. ( Diao, QZ; Gu, ZD; Shi, T, 2021) |
| "This was a prospective clinical trial conducted at Khartoum Fertility Center, during the period June 2002 to February 2005 to investigate the efficacy of unfractionated heparin and low-dose aspirin as prophylaxis against pregnancy loss in 58 pregnant Sudanese women with recurrent (> or = 3) miscarriages associated with antiphospholipid syndrome (APS)." | 5.12 | Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies. ( A/Magid, YM; A/Rahim, F; Adam, I; Elussein, EA; Omer, MM; Samaan, SI, 2007) |
| "To examine whether there were any differences in the endocrinological profiles during conception cycle and early pregnancy between a control group and women with a history of recurrent miscarriage that was caused by antiphospholipid syndrome and that was treated with aspirin and low molecular weight heparin." | 5.12 | Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin. ( Laird, S; Ledger, WL; Li, TC; Prakash, A, 2006) |
| "To compare the effect of aspirin and enoxaparin on live births in women with unexplained recurrent miscarriages, as well as secondary outcomes including birth weight, uterine and umbilical blood flows, and congenital malformations." | 5.12 | A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. ( Brenner, B; Carp, H; Dolitzky, M; Inbal, A; Segal, Y; Weiss, A, 2006) |
| " Low-molecular-weight heparin and low-dose aspirin daily during pregnancy were used in 29 selected cases with acquired and inherited thrombophilia." | 5.12 | Thrombophilia and antithrombotic therapy in women with recurrent spontaneous abortions. ( Deligiannidis, A; Mavridis, P; Mavroudi, A; Papastavrou, T; Parapanissiou, E; Tabakoudis, G; Tabakoudis, P, 2007) |
| "To evaluate the use of low-molecular-weight heparin (LMWH) in combination with low-dose aspirin (LDA) for the treatment of antiphospholipid antibody (APA)-associated recurrent pregnancy loss and to compare the results with the use of unfractionated heparin (UFH) plus LDA." | 5.11 | Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. ( Franklin, RD; Herrada, J; Kutteh, WH; Lashey, N; Noble, LS, 2005) |
| "The aim of this study was to evaluate the effects of two different prophylactic protocols, low-dose aspirin and fish oil derivates, in the treatment of patients with recurrent pregnancy loss associated with antiphospholipid antibodies (APA) syndrome." | 5.11 | Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates. ( Carta, G; Falciglia, K; Iovenitti, P, 2005) |
| "05) in pregnancy outcomes between the two studied therapeutic protocols, but the therapy with aspirin and low-molecular heparin was cheaper and easier to apply than the therapy with immunoglobulins." | 5.11 | Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. ( Dukanac, J; Gojnić, M; Jeremić, K; Ljubić, A; Pervulov, M; Stojnić, J, 2005) |
| "To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low-dose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL)." | 5.10 | Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. ( Accardo-Palumbo, A; Castelli, A; Ciccia, F; Ferrante, A; Giarratano, A; Licata, G; Perino, A; Triolo, G, 2003) |
| " These 16 patients with unexplained abortions were treated with aspirin, 80 mg per day, and a successful pregnancy outcome was observed in 10 patients, while 2 patients were in the third trimester of pregnancy." | 5.10 | Prevalence of anticardiolipin antibody IgG in recurrent first trimester abortions and the role of aspirin in its prevention. ( Choudhry, R; Kalra, S; Raheja, S; Tuli, A, 2003) |
| "This is a prospective clinical trial with 11 patients with RSA associated with allo- and autoimmunity not receiving lymphocyte immunizations but only heparin and aspirin preconceptionally and through pregnancy." | 5.09 | Heparin plus aspirin as a "single" therapy for recurrent spontaneous abortion associated with both allo- and autoimmunity. ( Beer, A; Botero, J; Cadavid, A; García, G; Ossa, J; Peña, B; Sánchez, F, 1999) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 5.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "In patients with aPL syndrome, IVIG treatment improved pregnancy outcome, with significantly lower pregnancy complication rates, when compared with prednisone plus LDA therapy." | 5.09 | Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. ( Cesa, F; Di Pierro, G; Lazzarin, N; Menghini, S; Romanini, C; Valensise, H; Vaquero, E, 2001) |
| "This study was conducted to determine if lower dose heparin (LD Heparin) combined with aspirin is as efficacious as higher dose heparin (HD Heparin) for the treatment of the antiphospholipid antibody syndrome in women seeking pregnancy." | 5.08 | A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. ( Ermel, LD; Kutteh, WH, 1996) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 5.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| " We evaluated the effect of a low-dose aspirin (LDA) on PGI2 and TXA2 production and on pregnancy outcome in RSA women with and without detectable anticardiolipin antibodies (ACA)." | 5.08 | Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. ( Ailus, K; Foudila, T; Marttunen, M; Palosuo, T; Söderstrom-Anttila, V; Tulppala, M; Ylikorkala, O, 1997) |
| "Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL)." | 5.05 | Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. ( Goddijn, M; Hamulyák, EN; Marijnen, MC; Middeldorp, S; Scheres, LJ, 2020) |
| "An improvement of pregnancy outcomes in women with RSA and APS can be achieved by treatment strategies combining low-dose aspirin plus heparin or heparin alone." | 5.01 | Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. ( Jiang, HL; Liu, Y; Lu, C, 2019) |
| "The use of aspirin and heparin has improved the pregnancy outcome in obstetric APS and approximately 70% of pregnant women with APS have a successful pregnancy outcome." | 4.95 | Current insights in obstetric antiphospholipid syndrome. ( Radin, M; Schreiber, K; Sciascia, S, 2017) |
| "To determine in women with hereditary thrombophilia whether the use of the combination of low-molecular-weight heparin (LMWH) and aspirin (ASA) is better than ASA alone." | 4.93 | Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. ( Areia, AL; Areia, M; Fonseca, E; Moura, P, 2016) |
| " Current treatment of patients with antiphospholipid syndrome (APS) during pregnancy with heparin and aspirin can act by preventing clot formation and improving live birth rates, but other obstetric morbidities remain high, especially in patients with a history of thrombotic events." | 4.90 | Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? ( de Jesús, GR; de Jesús, NR; Levy, RA; Rodrigues, G, 2014) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 4.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 4.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "To estimate the effect of combined heparin and aspirin compared with aspirin monotherapy in pregnant women with antiphospholipid syndrome and recurrent pregnancy loss." | 4.86 | Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. ( Pavlou, M; Voulgarelis, M; Ziakas, PD, 2010) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia." | 4.85 | Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. ( Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2009) |
| " Clinical trials have demonstrated that patients with antiphospholipid antibodies and venous thromboembolism should be treated with vitamin K antagonists (warfarin); that ischemic stroke may be treated with aspirin or warfarin; and that women with recurrent pregnancy loss should receive prophylactic-dose heparin and aspirin." | 4.85 | Antiphospholipid antibody syndrome. ( Lim, W, 2009) |
| " Combined aspirin and heparin for antiphospholipid syndrome, and screening and treatment of bacterial vaginosis between ten and 22 weeks of pregnancy with clindamycin, are the only interventions proven to be useful in randomised controlled trials (RCTs)." | 4.84 | Non-surgical interventions for threatened and recurrent miscarriages. ( Tan, TY; Tien, JC, 2007) |
| " The management of pregnant patients with antiphospholipid syndrome is mainly based on the use of antiaggregant/anticoagulant agents (with aspirin and heparin) to prevent thrombosis in the uteroplacental circulation." | 4.82 | The management of pregnant patients with antiphospholipid syndrome. ( Balasch, J; Cervera, R, 2004) |
| " The recurrent pregnancy loss that is associated with this disease is managed with prophylactic low dose aspirin and heparin therapy." | 4.82 | Immunologic manipulation for the threatened fetus. ( Benson, EM, 2004) |
| " Unfractionated heparin combined with aspirin (two trials; n = 140) significantly reduced pregnancy loss compared to aspirin alone (relative risk (RR) 0." | 4.82 | Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. ( Craig, J; Empson, M; Lassere, M; Scott, J, 2005) |
| " Aspirin, prednisone and heparin are most commonly utilized but are not clearly proven to outperform expectant management except in case of antiphospholipid syndrome." | 4.81 | [Medical treatment for recurrent miscarriages]. ( Belaisch-Allart, J; Mayenga, JM, 2002) |
| "Combination therapy with aspirin and heparin may reduce pregnancy loss in women with antiphospholipid antibodies by 54%." | 4.81 | Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. ( Craig, JC; Empson, M; Lassere, M; Scott, JR, 2002) |
| " It seems effective for the prevention of recurrent pregnancy losses when conventional strategies using subcutaneous heparin and low-dose aspirin have failed." | 4.80 | [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. ( Lê Thi Huong, D; Piette, JC; Wechsler, B, 2000) |
| "Aspirin has a well established role in the prevention of arterial thrombosis." | 4.79 | Aspirin in essential thrombocythemia: status quo and quo vadis. ( Bangerter, M; Griesshammer, M; Michiels, JJ; van Vliet, HH, 1997) |
| "To analyze the uterine artery blood flow parameters of patients with recurrent spontaneous abortion (RSA) at different gestational ages and to investigate the effects of aspirin and low molecular weight heparin (LMWH) on uterine artery blood flow parameters and pregnancy outcomes." | 4.31 | Analysis of the guidance and predictive value of uterine artery flow parameters in patients with recurrent spontaneous abortion. ( Lian, X; Mao, C; Pan, Z; Xia, F; Zhong, Y; Zhou, W; Zhou, Y, 2023) |
| "To assess the clinical efficacy of intravenous immunoglobulin G (IVIG) administration combined with low-dose aspirin in women with unexplained recurrent pregnancy loss (RPL)." | 4.12 | Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. ( Chae, HD; Kim, JH; Kim, SH; Ko, Y; Lee, SR; Yang, N, 2022) |
| "In this post hoc study, arachidonic acid (AA)-induced platelet aggregation during pregnancy with and without acetylsalicylic acid (ASA) treatment was studied in 323 women with unexplained recurrent first-trimester miscarriage and in 59 healthy women with normal pregnancies." | 4.12 | Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study. ( Blomqvist, LRF; Hellgren, MSE; Jeppsson, A; Strandell, AM, 2022) |
| "To assess the differences in Doppler parameters of endometrial receptivity in unexplained recurrent biochemical pregnancy loss (URBPL) and the therapeutic effect of low-dose aspirin (LDA)." | 4.12 | Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss. ( Bai, W; Guo, F; Wang, Q; Zhang, X; Zhao, A, 2022) |
| "To investigate the therapeutic role of prednisone in patients having unexplained recurrent pregnancy loss (URPL) with positivity of antinuclear antibodies (ANA) and the relationship between ANA titers, prednisone, and pregnancy outcomes." | 4.02 | Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss. ( Chen, C; Guo, F; Kou, X; Li, C; Sun, S; Zhao, A, 2021) |
| " These patients were grouped into three groups according to their treatment plan including those who received low dose aspirin (LDA) alone (group A), LDA plus LMWH after ovulation therapy (group B), and LDA plus LMWH after pregnancy confirmation (group C)." | 3.96 | D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody. ( Bao, SH; Frempong, ST; Ruan, JL, 2020) |
| "To evaluate differences in Doppler parameters and pregnancy outcomes, if any, and to determine the predictive accuracy of such indices, as well as the effects of low-dose aspirin (LDA) in unexplained recurrent pregnancy loss (URPL)." | 3.96 | Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss. ( He, L; Kang, X; Liu, F; Liu, Z; Wang, T; Zhao, A, 2020) |
| "The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody syndrome (APS) includes prolonged treatment with heparin and aspirin, starting from the confirmation of pregnancy and continuing until 6 weeks after birth." | 3.85 | Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study. ( Chi, HB; Liu, P; Qiao, J; Song, Y; Wang, HY, 2017) |
| "This prospective study aimed to evaluate pregnancy outcome and complications in women with recurrent pregnancy loss (RPL) and protein S (PS) deficiency, who received low dose aspirin (LDA) or LDA plus heparin (LDA/H) therapies." | 3.83 | Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss. ( Deguchi, M; Ebina, Y; Morizane, M; Shinozaki, N; Tanimura, K; Yamada, H, 2016) |
| "To study the effect of prophylactic use of low dose aspirin and heparin on patients with recurrent unexplained pregnancy loss." | 3.83 | The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion. ( Abdelhafiz, A; El-Nassery, N; Fouad, M; Kotb, A; Maged, AM; Mostafa, WA; Salah, E, 2016) |
| " When treatment was analyzed, 53/67 (79%) of women with APLAs who had received aspirin and heparin during their pregnancy had a live birth, compared with 64/104 (62%) of women with APLAs who received aspirin only (adjusted OR 2." | 3.76 | Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. ( Cohn, DM; Dawood, F; Farquharson, RG; Goddijn, M; Korevaar, JC; Middeldorp, S, 2010) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 3.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss." | 3.74 | Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. ( Kumagai, K; Nakanishi, T; Ozaki, Y; Sato, T; Sugiura-Ogasawara, M; Suzumori, N, 2008) |
| "Management recommendations displayed reasonable consistence: (i) for the use of low-dose aspirin and low-molecular weight heparin during pregnancy and during ovarian stimulation for in vitro fertilization; (ii) against oestrogen-containing oral contraceptives; and (iii) for the use of anticoagulants in the post-partum period." | 3.74 | Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. ( Erkan, D; Gerosa, M; Lockshin, MD; Meroni, PL; Nuzzo, M; Patel, S; Tincani, A, 2008) |
| "Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome." | 3.73 | Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. ( Black, S; Bose, P; Huppertz, B; Kadyrov, M; Neulen, J; Regan, L; Weissenborn, U, 2005) |
| "Our results reaffirm previous reports that the use of LMWH in combination with low dose aspirin throughout pregnancy is safe and effective." | 3.73 | Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology. ( Delkos, D; Giannoulis, H; Gkoutzioulis, F; Kalogiros, G; Papaloukas, C; Petropoulos, P; Psarra, A; Tzafettas, J, 2005) |
| "We treated four pregnancy cases positive for antiphospholipid antibodies (APLs) who had experienced recurrent second trimester fetal or neonatal losses using a Japanese modified Chinese herbal medicine, Sairei-to, low dose aspirin and adrenocorticosteroid hormone." | 3.72 | Effect of sairei-to combined with aspirin and prednisolone on four recurrent reproductive failure women who are positive for anti-phospholipid antibodies. ( Adachi, H; Ishii, K; Kurabayasi, T; Kurata, H; Natsume, N; Takaki, Y; Takakuwa, K; Tamura, M; Tanaka, K, 2003) |
| " Aspirin, 75 mg daily was given in addition to enoxaparin to women with antiphospholipid syndrome." | 3.70 | Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. ( Blumenfeld, Z; Brenner, B; Hoffman, R; Weiner, Z; Younis, JS, 2000) |
| " The question of whether anti-GM3 antibodies might exert influence in APLs-positive recurrent pregnancy loss patients who are undergoing prednisolone and aspirin (PSL/ASA) treatment was investigated." | 3.69 | Clinical significance of anti-GM3 antibodies in recurrent pregnancy loss with elevated level of antiphospholipid antibodies. ( Aoki, K; Aoyama, T; Kunimatsu, M; Ozaki, Y, 1995) |
| "Fifteen patients with previous pregnancy losses and positive plasma anticardiolipin antibody (ACA) were treated with prednisone (15 mg/day) and aspirin (80 mg/day)." | 3.68 | Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody. ( Cohen, AW; Forouzan, I; Lindenbaum, C; Samuels, P, 1993) |
| " Four of them achieved pregnancy after low-dose aspirin therapy was started, and carried successfully to term." | 3.68 | Antiphospholipid antibodies in unselected patients with repeated abortion. ( Balasch, J; Casals, FJ; Cervera, R; Font, J; Jové, I; López-Soto, A; Vanrell, JA, 1990) |
| " Despite preeclampsia our patient successfully completed her 6th pregnancy after treatment with corticosteroids, subcutaneous heparin, and low dose aspirin throughout the pregnancy." | 3.67 | Subclinical autoimmune disease and recurrent spontaneous abortion. ( Andreoli, J; Hakim, C; Maier, D; Parke, A; Randolph, J, 1986) |
| "Among 101 women with recurrent miscarriages, overall, 652 pregnancies have been included in the analysis." | 3.01 | Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. ( Antoine, JM; Ben Kraiem, Y; Bornes, M; Chabbert Buffet, N; Cheloufi, M; Cohen, J; Dabi, Y; Darai, E; Dechartres, A; Delhommeau, F; Fain, O; Johanet, C; Kayem, G; Kolanska, K; Ledée, N; Mathieu d'Argent, E; Mekinian, A; Placais, L; Rosefort, A; Selleret, L; Suner, L, 2021) |
| "Aspirin and heparin have been shown to have potentially beneficial effects on trophoblast implantation." | 2.79 | Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. ( Adam, I; Ashur, BM; Elbareg, AM; Elmahashi, MO; Essadi, FM, 2014) |
| "Thrombophilia has been identified in about 50% of women with recurrent miscarriage and thromboprophylaxis has been suggested as an option of treatment." | 2.76 | Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. ( Bloemenkamp, KW; Helmerhorst, FM; Kaaja, RJ; Lampinen, K; Morin-Papunen, L; Ulander, VM; Visser, J, 2011) |
| "In women with a history of recurrent miscarriage, the risk of miscarriage in a subsequent pregnancy is about 30% to 40%." | 2.74 | Use of heparin in women with early and late miscarriages with and without thrombophilia. ( Baumgarten, S; Dörner, T; Kadecki, O; Kiesewetter, H; Monien, S; Salama, A, 2009) |
| "Pregnancy was successfully carried out in 12/12 (100%) SLE-RSA patients with a mean Apgar score of 8." | 2.73 | Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. ( Cipriani, P; De Carolis, C; Fontana, L; Giacomelli, R; Greco, E; Kröegler, B; Perricone, C; Perricone, R, 2008) |
| "Pregnancy is a prothrombotic condition, which can be abnormally exaggerated in women with thrombophilia." | 2.72 | Inherited thrombophilia and anticoagulant therapy for women with reproductive failure. ( Han, AR; Han, JW; Lee, SK, 2021) |
| " Six hundred eighty-seven APA+ women, who were younger than 40 years and who each, completed up to three consecutive IVF/embryo transfer cycles within a 12-month period, were given either H/A alone or H/A in combination with IVIg." | 2.69 | The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. ( Ching, W; Chong, P; Feinman, M; Maassarani, G; Matzner, W; Sher, G; Zouves, C, 1998) |
| "Recurrent miscarriage and later pregnancy complications are in some cases associated with placental thrombosis and infarction." | 2.69 | Recurrent miscarriage--an aspirin a day? ( Backos, M; Baxter, N; Chilcott, I; Rai, R; Regan, L, 2000) |
| "Treatment with aspirin and heparin leads to a significantly higher rate of live births in women with a history of recurrent miscarriage associated with phospholipid antibodies than that achieved with aspirin alone." | 2.68 | Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) ( Cohen, H; Dave, M; Rai, R; Regan, L, 1997) |
| "To compare the efficacy of heparin combined with aspirin and aspirin alone for URSA." | 2.66 | Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion. ( Gao, YH; Li, J; Li, ZY; Xu, L, 2020) |
| "Compared with control intervention for recurrent miscarriage, enoxaparin treatment has no substantial influence on live births (RR = 1." | 2.61 | Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies. ( Chen, Y; Cheng, X; Li, N; Lin, T; Sheng, X, 2019) |
| "Sixty-eight patients with unexplained recurrent miscarriage were randomized to receive either G-CSF (filgastrim, Neupogen, 1 μ/kg/day SC, n = 35) after the ovulation until the 9th weeks of gestation or placebo (n = 33)." | 2.53 | Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? ( Alijotas-Reig, J; Bornes, M; Carbillon, L; Cohen, J; Daraï, E; Fain, O; Kayem, G; Mekinian, A; Nicaise-Roland, P, 2016) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.50 | Antiphospholipid antibody syndrome. ( Hinote, CD; Kutteh, WH, 2014) |
| "The optimum treatment for patients with recurrent miscarriage and a confirmed thrombophilia remains a contentious issue." | 2.48 | Recurrent miscarriage and thrombophilia: an update. ( Dawood, F; Farquharson, R; McNamee, K, 2012) |
| "Treatment with aspirin and heparin decreases the risk of miscarriages in APS." | 2.47 | Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). ( Burmester, GR; Dörner, T; Hoppe, B, 2011) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.47 | Obstetric antiphospholipid syndrome: an update on pathophysiology and management. ( Ernest, JM; Kutteh, WH; Marshburn, PB, 2011) |
| "Treatment with aspirin inhibited miR-20b-5p levels, thus restoring primary cilia formation and trophoblast invasion." | 2.44 | Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage. ( Chao, YY; Lin, RC; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2024) |
| " Due to lack of complete randomized investigation about the inclusion of antithrombotic prophylaxis in this group of pregnant women, common scheme of administration and optimal dosage is yet to be established." | 2.44 | [Inherited thrombophilia in women with recurrent miscarriages and pregnancy loss in anamnesis--own experience]. ( Drews, K; Kaluba-Skotarczak, A; Puacz, P; Seremak-Mrozikiewicz, A, 2008) |
| "The 'antiphospholipid antibody syndrome' has been described in women with a history of recurrent pregnancy loss or thrombosis with positive APA or lupus anticoagulant on two occasions." | 2.42 | Low molecular weight heparin in immunological recurrent abortion--the incredible cure. ( Allahbadia, GN; Allahbadia, SG, 2003) |
| "The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients." | 2.42 | Antiphospholipid syndrome in obstetrics. ( Heilmann, L; Pollow, K; von Tempelhoff, GF, 2003) |
| "Antiphospholipid syndrome is a multisystem disease with the predominant features of venous and arterial thrombosis, recurrent pregnancy loss, foetal death and the presence of antiphospholipid antibodies." | 2.41 | Antiphospholipid syndrome and recurrent miscarriages. ( Cosson, M; Dufour, P; Houpeau, JL; Vinatier, D, 2001) |
| "Normal mammalian pregnancy is confronted with a great number of self (autoimmune) and foreign (alloimmune) antigens that modulate the immune system of the mother." | 2.38 | Current status of immunologic recurrent pregnancy loss. ( Coulam, CB; Stern, JJ, 1993) |
| "The use of prophylactic treatments against thrombophilia becomes necessary in order to increase the live birth rates in women with RPL." | 1.56 | Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages? ( Aslan, I; Ozyigit, S; Paul, LT; Tosun, O; Tulay, P, 2020) |
| "In this series, recurrent miscarriage is the most frequent poor outcome." | 1.51 | The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. ( Alijotas-Reig, J; Arnau, A; Belizna, C; Canti, V; Cervera, R; Chighizola, CB; De Carolis, S; Espinosa, G; Esteve-Valverde, E; Farran-Codina, I; Ferrer-Oliveras, R; Gerosa, M; Gogou, V; Hoxha, A; Latino, O; Lefkou, E; LLurba, E; Lundelin, K; Marozio, L; Martí-Cañamares, A; Mayer-Pickel, K; Mekinian, A; Pengo, V; Reshetnyak, T; Ríos-Garcés, R; Rovere-Querini, P; Ruffatti, A; Ruiz-Hidalgo, D; Sáez-Comet, L; Sos, L; Stojanovich, L; Stoppani, C; Tabacco, S; Tincani, A; Trapé, J; Varoudis, A, 2019) |
| "Recurrent spontaneous abortion is one of the common complications in women of childbearing age during pregnancy." | 1.48 | [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. ( Li, XY; Liu, XY; Zhao, JX, 2018) |
| "Obstetrical APS with isolated recurrent miscarriages is mostly associated with isolated anticardiolipids antibodies and have better obstetrical outcome." | 1.46 | [Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?] ( Abisror, N; Bornes, M; Carbillon, L; Cohen, J; Fain, O; Josselin-Mahr, L; Kayem, G; Mekinian, A, 2017) |
| "An autoimmune disease was present in seven (29%) cases." | 1.42 | Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015) |
| "Of these women, 74 had a history of recurrent miscarriage (1." | 1.42 | Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center. ( Nakanishi, K; Suzuki, S; Terada, K, 2015) |
| "Women with inherited thrombophilia and recurrent miscarriage might benefit from preconceptional antiagreggation with low-dose acetylsalicylic acid (ASA), but concerns about severe adverse reactions may prevent physicians from performing this treatment in patients with ASA hypersensitivity." | 1.38 | Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage. ( Gaspar, A; Livramento, S; Morais-Almeida, M; Sampaio, G; Santos, N, 2012) |
| "Preterm birth was more frequent in study group than general population (21." | 1.38 | Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility. ( Ahn, H; Beaman, K; Gilman-Sachs, A; Han, AR; Kwak-Kim, J; Park, JC; Vu, P, 2012) |
| "Thus, in order to diagnose and treat pregnancy-triggered APS in patients with unexplained recurrent miscarriage, screening for APL should also be performed at several time points after conception." | 1.36 | Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages. ( Engel, JB; Häusler, S; Honig, A; Kranke, P; Segerer, SE; Würfel, W, 2010) |
| "Antiphospholipid syndrome is a recognized disorder of pregnancy." | 1.33 | Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up. ( Khurshid, M; Naru, T; Nazir, Z, 2006) |
| "Since completion of the recurrent miscarriage analysis, 39 women conceived again." | 1.32 | Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias. ( Dekker, GA; Krabbendam, I, 2004) |
| "Autoimmune diseases are a group of illnesses in which autoantibodies are produced against various organs, presenting with a variety of clinical symptoms." | 1.32 | Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. ( Chen, L; Miller, RK; Ornoy, A; Silver, RM, 2004) |
| "Among the patients treated (n = 38) thrombophilia screening was positive in 16 patients and in the remaining 22 no causative factor was detected." | 1.31 | Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology. ( Anapliotis, A; Klearchou, N; Loufopoulos, A; Mamopoulos, A; Mamopoulos, M; Psarra, A; Tzafettas, J, 2002) |
| "Two patients had systemic lupus erythematosus, and the other five fulfilled criteria for the primary antiphospholipid syndrome." | 1.28 | Fetal loss treatment in patients with antiphospholipid antibodies. ( Barquinero, J; Genover, E; Jordana, R; Ordi, J; Selva, A; Tolosa, C; Vilardell, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (4.24) | 18.7374 |
| 1990's | 48 (20.34) | 18.2507 |
| 2000's | 81 (34.32) | 29.6817 |
| 2010's | 68 (28.81) | 24.3611 |
| 2020's | 29 (12.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, N | 1 |
| Khan, SA | 1 |
| Yiu, ME | 1 |
| Jubiz, G | 1 |
| Salazar, MD | 1 |
| Skariah, A | 1 |
| Dambaeva, S | 2 |
| Kwak-Kim, J | 4 |
| Yan, X | 1 |
| Wang, D | 1 |
| Yan, P | 1 |
| Li, H | 1 |
| Zhu, D | 2 |
| Zou, H | 2 |
| Liu, J | 2 |
| Wang, J | 3 |
| Ma, C | 1 |
| Yin, J | 2 |
| Peng, X | 1 |
| Li, D | 1 |
| Yang, Y | 1 |
| Ren, Y | 1 |
| Zhang, Z | 2 |
| Zhou, P | 1 |
| Wang, X | 1 |
| Cao, Y | 2 |
| Xu, X | 2 |
| Hodgetts Morton, V | 1 |
| Stock, SJ | 1 |
| Kim, JH | 1 |
| Kim, SH | 1 |
| Yang, N | 1 |
| Ko, Y | 1 |
| Lee, SR | 1 |
| Chae, HD | 1 |
| Zhang, Y | 1 |
| Song, Y | 2 |
| Xia, X | 1 |
| Qian, Y | 1 |
| Yuan, C | 1 |
| Mao, Y | 1 |
| Diao, F | 1 |
| Ma, X | 1 |
| Fu, Z | 1 |
| Ding, X | 1 |
| Wei, D | 1 |
| Li, J | 2 |
| Cang, R | 1 |
| Li, X | 1 |
| Lian, X | 1 |
| Pan, Z | 1 |
| Xia, F | 1 |
| Mao, C | 1 |
| Zhou, W | 1 |
| Zhong, Y | 1 |
| Zhou, Y | 1 |
| Regan, L | 8 |
| Rai, R | 6 |
| Saravelos, S | 2 |
| Li, TC | 3 |
| Dhillon-Smith, RK | 1 |
| Melo, P | 1 |
| Kaur, R | 1 |
| Fox, E | 1 |
| Devall, A | 1 |
| Woodhead, N | 1 |
| Coomarasamy, A | 1 |
| Lin, RC | 1 |
| Chao, YY | 1 |
| Su, MT | 1 |
| Tsai, HL | 1 |
| Tsai, PY | 1 |
| Wang, CY | 1 |
| Wang, M | 2 |
| Zhang, P | 1 |
| Yu, S | 1 |
| Zhou, G | 1 |
| Lv, J | 1 |
| Nallapothula, D | 1 |
| Guo, C | 1 |
| Wang, Q | 2 |
| Singh, RR | 1 |
| Ou, H | 1 |
| Yu, Q | 1 |
| Bao, SH | 3 |
| Chigirin, N | 1 |
| Hoch, V | 1 |
| Ahmed, H | 1 |
| Frempong, ST | 3 |
| Zhang, M | 1 |
| Ruan, JL | 2 |
| Karadağ, C | 1 |
| Akar, B | 1 |
| Gönenç, G | 1 |
| Aslancan, R | 1 |
| Yılmaz, N | 1 |
| Çalışkan, E | 1 |
| Xiang, H | 1 |
| Wang, T | 1 |
| Kang, X | 2 |
| Zhao, A | 4 |
| He, L | 1 |
| Liu, Z | 2 |
| Liu, F | 1 |
| Hamulyák, EN | 1 |
| Scheres, LJ | 1 |
| Marijnen, MC | 1 |
| Goddijn, M | 6 |
| Middeldorp, S | 6 |
| Gao, YH | 1 |
| Xu, L | 1 |
| Li, ZY | 1 |
| Aslan, I | 1 |
| Ozyigit, S | 1 |
| Paul, LT | 1 |
| Tosun, O | 1 |
| Tulay, P | 1 |
| Yang, Z | 1 |
| Shen, X | 1 |
| Zhou, C | 1 |
| Liu, Y | 2 |
| Zhou, L | 1 |
| Han, AR | 2 |
| Han, JW | 1 |
| Lee, SK | 1 |
| Gangat, N | 2 |
| Tefferi, A | 2 |
| Sun, S | 1 |
| Li, C | 1 |
| Kou, X | 1 |
| Chen, C | 1 |
| Guo, F | 2 |
| Blomqvist, LRF | 1 |
| Strandell, AM | 1 |
| Jeppsson, A | 1 |
| Hellgren, MSE | 1 |
| Kolanska, K | 2 |
| Dabi, Y | 1 |
| Dechartres, A | 1 |
| Cohen, J | 4 |
| Ben Kraiem, Y | 1 |
| Selleret, L | 1 |
| Mathieu d'Argent, E | 1 |
| Placais, L | 1 |
| Cheloufi, M | 1 |
| Johanet, C | 2 |
| Rosefort, A | 1 |
| Bornes, M | 4 |
| Suner, L | 1 |
| Delhommeau, F | 1 |
| Ledée, N | 1 |
| Chabbert Buffet, N | 1 |
| Darai, E | 2 |
| Antoine, JM | 1 |
| Fain, O | 6 |
| Kayem, G | 4 |
| Mekinian, A | 7 |
| Guglielmelli, P | 1 |
| Al-Kali, A | 1 |
| Wolanskyj-Spinner, AP | 1 |
| Camoriano, J | 1 |
| Patnaik, MM | 1 |
| Pardanani, A | 1 |
| Hanson, CA | 1 |
| Vannucchi, AM | 1 |
| Chen, Y | 2 |
| Wu, Q | 1 |
| Wei, J | 1 |
| Hu, J | 2 |
| Zheng, S | 1 |
| Shi, T | 1 |
| Gu, ZD | 1 |
| Diao, QZ | 1 |
| Zhang, X | 2 |
| Bai, W | 1 |
| Abdulghani, S | 1 |
| Moretti, F | 1 |
| Gruslin, A | 1 |
| Grynspan, D | 1 |
| Schreiber, K | 1 |
| Radin, M | 1 |
| Sciascia, S | 1 |
| Sheng, SL | 1 |
| Liao, H | 2 |
| Zhou, Q | 1 |
| Tu, WY | 1 |
| Lu, C | 1 |
| Jiang, HL | 1 |
| Chighizola, CB | 2 |
| Shoenfeld, Y | 1 |
| Meroni, PL | 2 |
| Blomqvist, L | 1 |
| Hellgren, M | 1 |
| Strandell, A | 1 |
| Kemp, M | 1 |
| Thomas, W | 1 |
| Nonaka, T | 1 |
| Takahashi, M | 1 |
| Nonaka, C | 1 |
| Haino, K | 1 |
| Yamaguchi, M | 1 |
| Enomoto, T | 1 |
| Takakuwa, K | 4 |
| Li, XY | 1 |
| Zhao, JX | 1 |
| Liu, XY | 1 |
| Lin, T | 1 |
| Cheng, X | 1 |
| Li, N | 1 |
| Sheng, X | 1 |
| Alijotas-Reig, J | 3 |
| Esteve-Valverde, E | 1 |
| Ferrer-Oliveras, R | 2 |
| Sáez-Comet, L | 1 |
| Lefkou, E | 1 |
| Belizna, C | 1 |
| Ruffatti, A | 1 |
| Tincani, A | 2 |
| Marozio, L | 1 |
| Espinosa, G | 1 |
| Cervera, R | 3 |
| Ríos-Garcés, R | 1 |
| De Carolis, S | 2 |
| Latino, O | 1 |
| LLurba, E | 1 |
| Gerosa, M | 2 |
| Pengo, V | 1 |
| Lundelin, K | 1 |
| Rovere-Querini, P | 1 |
| Canti, V | 1 |
| Mayer-Pickel, K | 1 |
| Reshetnyak, T | 1 |
| Hoxha, A | 1 |
| Tabacco, S | 1 |
| Stojanovich, L | 1 |
| Gogou, V | 1 |
| Varoudis, A | 1 |
| Arnau, A | 1 |
| Ruiz-Hidalgo, D | 1 |
| Trapé, J | 1 |
| Sos, L | 1 |
| Stoppani, C | 1 |
| Martí-Cañamares, A | 1 |
| Farran-Codina, I | 1 |
| Houfflin-Debarge, V | 1 |
| Abisror, N | 2 |
| Solt, I | 1 |
| Ben David, C | 1 |
| Carp, H | 2 |
| Santos, N | 1 |
| Gaspar, A | 1 |
| Livramento, S | 1 |
| Sampaio, G | 1 |
| Morais-Almeida, M | 1 |
| Agcaoili, MS | 1 |
| Aleta, L | 1 |
| Liao, A | 1 |
| Ota, K | 1 |
| Beaman, K | 2 |
| Kim, JW | 1 |
| Gilman-Sachs, A | 3 |
| Bloor, M | 1 |
| Paech, M | 1 |
| Chakraborty, P | 1 |
| Banerjee, S | 1 |
| Saha, P | 1 |
| Nandi, SS | 1 |
| Sharma, S | 1 |
| Goswami, SK | 1 |
| Chakravarty, B | 1 |
| Kabir, SN | 1 |
| de Jesús, GR | 1 |
| Rodrigues, G | 1 |
| de Jesús, NR | 1 |
| Levy, RA | 1 |
| Yasuda, S | 1 |
| Elmahashi, MO | 1 |
| Elbareg, AM | 1 |
| Essadi, FM | 1 |
| Ashur, BM | 1 |
| Adam, I | 2 |
| Kutteh, WH | 8 |
| Hinote, CD | 1 |
| Gomaa, MF | 1 |
| Elkholy, AG | 1 |
| El-Said, MM | 1 |
| Abdel-Salam, NE | 1 |
| de Jong, PG | 2 |
| Kaandorp, S | 2 |
| Di Nisio, M | 2 |
| Costedoat-Chalumeau, N | 1 |
| Masseau, A | 1 |
| Botta, A | 1 |
| Chudzinski, A | 1 |
| Theulin, A | 1 |
| Emmanuelli, V | 1 |
| Hachulla, E | 1 |
| Revaux, A | 1 |
| Nicaise, P | 1 |
| Cornelis, F | 1 |
| Subtil, D | 1 |
| Montestruc, F | 1 |
| Bucourt, M | 1 |
| Chollet-Martin, S | 2 |
| Carbillon, L | 4 |
| Bao, S | 1 |
| Shuai, W | 1 |
| Wang, L | 1 |
| Mutlu, I | 1 |
| Mutlu, MF | 1 |
| Biri, A | 1 |
| Bulut, B | 1 |
| Erdem, M | 1 |
| Erdem, A | 1 |
| Terada, K | 1 |
| Nakanishi, K | 1 |
| Suzuki, S | 1 |
| Patil, R | 1 |
| Ghosh, K | 1 |
| Damania, K | 1 |
| Bansal, V | 1 |
| Satoskar, P | 1 |
| Darekar, A | 1 |
| Shetty, S | 1 |
| Areia, AL | 1 |
| Fonseca, E | 1 |
| Areia, M | 1 |
| Moura, P | 1 |
| Lu, X | 1 |
| Shen, W | 1 |
| Ismail, AM | 1 |
| Hamed, AH | 1 |
| Saso, S | 1 |
| Abu-Elhasan, AM | 1 |
| Abu-Elghar, MM | 1 |
| Abdelmeged, AN | 1 |
| Nicaise-Roland, P | 2 |
| Shinozaki, N | 1 |
| Ebina, Y | 1 |
| Deguchi, M | 1 |
| Tanimura, K | 1 |
| Morizane, M | 1 |
| Yamada, H | 2 |
| Ahrens, KA | 1 |
| Silver, RM | 3 |
| Mumford, SL | 1 |
| Sjaarda, LA | 1 |
| Perkins, NJ | 1 |
| Wactawski-Wende, J | 1 |
| Galai, N | 1 |
| Townsend, JM | 1 |
| Lynch, AM | 1 |
| Lesher, LL | 1 |
| Faraggi, D | 1 |
| Zarek, S | 1 |
| Schisterman, EF | 1 |
| Maged, AM | 1 |
| Abdelhafiz, A | 1 |
| Mostafa, WA | 1 |
| El-Nassery, N | 1 |
| Fouad, M | 1 |
| Salah, E | 1 |
| Kotb, A | 1 |
| Nahas, R | 1 |
| Saliba, W | 1 |
| Elias, A | 1 |
| Elias, M | 1 |
| Tong, L | 1 |
| Wei, X | 1 |
| Wang, HY | 1 |
| Qiao, J | 1 |
| Liu, P | 1 |
| Chi, HB | 1 |
| Josselin-Mahr, L | 1 |
| Roumi, JE | 1 |
| Moukhadder, HM | 1 |
| Graziadei, G | 1 |
| Pennisi, M | 1 |
| Cappellini, MD | 1 |
| Taher, AT | 1 |
| Lazzarin, N | 2 |
| Vaquero, E | 2 |
| Exacoustos, C | 1 |
| Bertonotti, E | 1 |
| Romanini, ME | 1 |
| Arduini, D | 1 |
| Ruan, Y | 1 |
| Bridges, JS | 1 |
| Kumar, K | 1 |
| Raphael, JA | 1 |
| Acharjee, S | 1 |
| Welty, FK | 1 |
| Skrzypczak, J | 1 |
| Casellas-Caro, M | 1 |
| Llurba-Olive, E | 1 |
| Hermosilla, E | 1 |
| Vilardell-Tarres, M | 1 |
| Cabero-Roura, L | 1 |
| Seremak-Mrozikiewicz, A | 1 |
| Drews, K | 1 |
| Puacz, P | 1 |
| Kaluba-Skotarczak, A | 1 |
| Dendrinos, S | 2 |
| Sakkas, E | 1 |
| Makrakis, E | 2 |
| Laskin, CA | 4 |
| Spitzer, KA | 3 |
| Clark, CA | 3 |
| Crowther, MR | 2 |
| Ginsberg, JS | 2 |
| Hawker, GA | 1 |
| Kingdom, JC | 1 |
| Barrett, J | 1 |
| Gent, M | 1 |
| Buckingham, KL | 1 |
| Chamley, LW | 1 |
| Duckitt, K | 2 |
| Qureshi, A | 2 |
| Carp, HJ | 3 |
| Krüger, K | 1 |
| Monien, S | 1 |
| Kadecki, O | 1 |
| Baumgarten, S | 1 |
| Salama, A | 1 |
| Dörner, T | 2 |
| Kiesewetter, H | 1 |
| Mo, D | 1 |
| Metwally, M | 1 |
| Makris, M | 1 |
| Mak, A | 1 |
| Cheung, MW | 1 |
| Cheak, AA | 1 |
| Ho, RC | 1 |
| Lim, W | 1 |
| Clark, P | 1 |
| Walker, ID | 1 |
| Langhorne, P | 1 |
| Crichton, L | 1 |
| Thomson, A | 1 |
| Greaves, M | 2 |
| Whyte, S | 1 |
| Greer, IA | 2 |
| Kaandorp, SP | 1 |
| van der Post, JA | 1 |
| Hutten, BA | 1 |
| Verhoeve, HR | 1 |
| Hamulyák, K | 1 |
| Mol, BW | 1 |
| Folkeringa, N | 1 |
| Nahuis, M | 1 |
| Papatsonis, DN | 1 |
| Büller, HR | 1 |
| van der Veen, F | 1 |
| Gelber, SE | 1 |
| Salmon, JE | 1 |
| Ziakas, PD | 1 |
| Pavlou, M | 1 |
| Voulgarelis, M | 1 |
| A/Magid, YM | 1 |
| Elussein, EA | 1 |
| Omer, MM | 1 |
| Samaan, SI | 1 |
| A/Rahim, F | 1 |
| Cohn, DM | 1 |
| Korevaar, JC | 1 |
| Dawood, F | 2 |
| Farquharson, RG | 1 |
| Pasquier, E | 1 |
| de Saint Martin, L | 1 |
| Le Gal, G | 1 |
| Visser, J | 2 |
| Cohen, D | 1 |
| Bloemenkamp, KW | 2 |
| Zeng, QL | 1 |
| Yao, MY | 1 |
| Honig, A | 1 |
| Engel, JB | 1 |
| Segerer, SE | 1 |
| Kranke, P | 1 |
| Häusler, S | 1 |
| Würfel, W | 1 |
| Ulander, VM | 1 |
| Helmerhorst, FM | 1 |
| Lampinen, K | 1 |
| Morin-Papunen, L | 1 |
| Kaaja, RJ | 2 |
| Fouda, UM | 1 |
| Sayed, AM | 1 |
| Abdou, AM | 1 |
| Ramadan, DI | 1 |
| Fouda, IM | 1 |
| Zaki, MM | 1 |
| Gris, JC | 2 |
| Hoppe, B | 1 |
| Burmester, GR | 1 |
| Alalaf, S | 1 |
| Galarza-Maldonado, C | 1 |
| Kourilovitch, MR | 1 |
| Pérez-Fernández, OM | 1 |
| Gaybor, M | 1 |
| Cordero, C | 1 |
| Cabrera, S | 1 |
| Soroka, NF | 1 |
| Ernest, JM | 1 |
| Marshburn, PB | 1 |
| Loire-Berson, P | 1 |
| Lachassinne, E | 1 |
| Stirnemann, J | 1 |
| Boffa, MC | 1 |
| McNamee, K | 1 |
| Farquharson, R | 1 |
| Ahn, H | 1 |
| Vu, P | 1 |
| Park, JC | 1 |
| Belaisch-Allart, J | 1 |
| Mayenga, JM | 1 |
| Franklin, RD | 2 |
| Hickstein, H | 1 |
| Barz, D | 1 |
| Külz, T | 1 |
| Korten, G | 1 |
| Müller, H | 1 |
| Schmidt, R | 1 |
| Triolo, G | 1 |
| Ferrante, A | 1 |
| Ciccia, F | 1 |
| Accardo-Palumbo, A | 1 |
| Perino, A | 1 |
| Castelli, A | 1 |
| Giarratano, A | 1 |
| Licata, G | 1 |
| Tzafettas, J | 2 |
| Mamopoulos, A | 1 |
| Anapliotis, A | 1 |
| Loufopoulos, A | 1 |
| Psarra, A | 2 |
| Klearchou, N | 1 |
| Mamopoulos, M | 1 |
| Allahbadia, GN | 1 |
| Allahbadia, SG | 1 |
| Heilmann, L | 1 |
| von Tempelhoff, GF | 1 |
| Pollow, K | 1 |
| Morikawa, M | 1 |
| Kato, EH | 1 |
| Shimada, S | 1 |
| Sakuragi, N | 1 |
| Fujimoto, S | 1 |
| Minakami, H | 1 |
| Kalra, S | 1 |
| Tuli, A | 2 |
| Choudhry, R | 2 |
| Raheja, S | 1 |
| Ruiz-Irastorza, G | 1 |
| Khamashta, MA | 4 |
| Hughes, GR | 1 |
| Lewandowski, K | 1 |
| Balcerzak, A | 1 |
| Kubiaczyk-Paluch, B | 1 |
| Breborowicz, GH | 1 |
| Carbonne, B | 1 |
| Lejeune, V | 1 |
| Daya, S | 1 |
| Ishii, K | 1 |
| Takaki, Y | 1 |
| Natsume, N | 1 |
| Adachi, H | 1 |
| Kurata, H | 1 |
| Tamura, M | 2 |
| Kurabayasi, T | 1 |
| Tanaka, K | 3 |
| Malinowski, A | 1 |
| Dyński, MA | 1 |
| Maciołek-Blewniewska, G | 1 |
| Głowacka, E | 1 |
| Pawłowski, T | 1 |
| Babula, G | 1 |
| Krabbendam, I | 1 |
| Dekker, GA | 1 |
| Balasch, J | 4 |
| Konova, E | 1 |
| Ivanova, I | 1 |
| Petrova, P | 1 |
| Popov, I | 1 |
| Andreeva, Kh | 1 |
| Lukanov, Ts | 1 |
| Gecheva, S | 1 |
| Ornoy, A | 1 |
| Chen, L | 1 |
| Miller, RK | 1 |
| Wisløff, F | 1 |
| Crowther, M | 1 |
| Jivraj, S | 1 |
| Benson, EM | 1 |
| Bose, P | 1 |
| Black, S | 1 |
| Kadyrov, M | 1 |
| Weissenborn, U | 1 |
| Neulen, J | 1 |
| Huppertz, B | 1 |
| Noble, LS | 1 |
| Lashey, N | 1 |
| Herrada, J | 1 |
| Empson, M | 2 |
| Lassere, M | 2 |
| Craig, J | 1 |
| Scott, J | 1 |
| Carta, G | 1 |
| Iovenitti, P | 1 |
| Falciglia, K | 1 |
| Petropoulos, P | 1 |
| Delkos, D | 1 |
| Papaloukas, C | 1 |
| Giannoulis, H | 1 |
| Kalogiros, G | 1 |
| Gkoutzioulis, F | 1 |
| Jeremić, K | 1 |
| Pervulov, M | 1 |
| Gojnić, M | 1 |
| Dukanac, J | 1 |
| Ljubić, A | 1 |
| Stojnić, J | 1 |
| Prakash, A | 1 |
| Laird, S | 1 |
| Ledger, WL | 1 |
| Wu, S | 1 |
| Stephenson, MD | 1 |
| Goel, N | 1 |
| Naru, T | 1 |
| Khurshid, M | 1 |
| Nazir, Z | 1 |
| Lindqvist, PG | 1 |
| Merlo, J | 1 |
| Tempfer, CB | 1 |
| Kurz, C | 1 |
| Bentz, EK | 1 |
| Unfried, G | 1 |
| Walch, K | 1 |
| Czizek, U | 1 |
| Huber, JC | 1 |
| Dolitzky, M | 1 |
| Inbal, A | 1 |
| Segal, Y | 1 |
| Weiss, A | 1 |
| Brenner, B | 3 |
| Bloom, MS | 1 |
| Whitcomb, BW | 1 |
| Derksen, RH | 1 |
| de Groot, PG | 1 |
| Aguilera, C | 1 |
| Agustí, A | 1 |
| Lett, C | 1 |
| Case, A | 1 |
| Baerwald, A | 1 |
| Deligiannidis, A | 1 |
| Parapanissiou, E | 1 |
| Mavridis, P | 1 |
| Tabakoudis, G | 1 |
| Mavroudi, A | 1 |
| Papastavrou, T | 1 |
| Tabakoudis, P | 1 |
| Kalogirou, I | 1 |
| Theodoridis, T | 1 |
| Mahmound, EA | 1 |
| Christopoulou-Cokkinou, V | 1 |
| Creatsas, G | 1 |
| Tien, JC | 1 |
| Tan, TY | 1 |
| Fawzy, M | 1 |
| Shokeir, T | 1 |
| El-Tatongy, M | 1 |
| Warda, O | 1 |
| El-Refaiey, AA | 1 |
| Mosbah, A | 1 |
| Bick, RL | 2 |
| Sugiura-Ogasawara, M | 1 |
| Ozaki, Y | 2 |
| Nakanishi, T | 1 |
| Sato, T | 1 |
| Suzumori, N | 1 |
| Kumagai, K | 1 |
| Perricone, R | 1 |
| De Carolis, C | 1 |
| Kröegler, B | 1 |
| Greco, E | 1 |
| Giacomelli, R | 1 |
| Cipriani, P | 1 |
| Fontana, L | 1 |
| Perricone, C | 1 |
| Erkan, D | 1 |
| Patel, S | 1 |
| Nuzzo, M | 1 |
| Lockshin, MD | 1 |
| Aoki, K | 5 |
| Aoyama, T | 3 |
| Kunimatsu, M | 1 |
| Silver, RK | 1 |
| Peaceman, AM | 1 |
| Adams, DM | 1 |
| Christiansen, OB | 4 |
| Lauritsen, JG | 2 |
| Kwak, JY | 1 |
| Barini, R | 1 |
| Beaman, KD | 1 |
| Beer, AE | 1 |
| Carmona, F | 1 |
| López-Soto, A | 2 |
| Font, J | 2 |
| Creus, M | 1 |
| Fábregues, F | 1 |
| Ingelmo, M | 1 |
| Vanrell, JA | 2 |
| al-Momen, AK | 1 |
| Moghraby, SA | 1 |
| el-Rab, MO | 1 |
| Gader, AM | 1 |
| al-Balla, SR | 1 |
| al-Meshari, AA | 1 |
| al-Nuaim, L | 1 |
| Lin, QD | 1 |
| Menashe, Y | 1 |
| Frenkel, Y | 1 |
| Many, A | 1 |
| Nebel, L | 1 |
| Toder, V | 1 |
| Mashiach, S | 1 |
| Stern, JJ | 1 |
| Coulam, CB | 2 |
| Forouzan, I | 1 |
| Cohen, AW | 1 |
| Lindenbaum, C | 1 |
| Samuels, P | 1 |
| Marco, P | 1 |
| Lucas, J | 1 |
| Alonso, A | 1 |
| Pérez Vázquez, J | 1 |
| Fernández, P | 1 |
| Victoria, C | 1 |
| García, MC | 1 |
| Calatayud, R | 1 |
| Ermel, LD | 1 |
| Rai, RS | 1 |
| Chitolie, A | 1 |
| Donald, JG | 1 |
| Cohen, H | 3 |
| Mackworth-Young, C | 1 |
| Dave, M | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Tulppala, M | 1 |
| Marttunen, M | 1 |
| Söderstrom-Anttila, V | 1 |
| Foudila, T | 1 |
| Ailus, K | 1 |
| Palosuo, T | 1 |
| Ylikorkala, O | 1 |
| Griesshammer, M | 1 |
| Bangerter, M | 1 |
| van Vliet, HH | 1 |
| Michiels, JJ | 1 |
| Piette, JC | 2 |
| Huong, DL | 1 |
| Wechsler, B | 2 |
| González Campos, J | 1 |
| Monedero, M | 1 |
| Vinuesa, M | 1 |
| Alvarez, D | 1 |
| Digón, J | 1 |
| Rodríguez, JM | 1 |
| Branch, DW | 1 |
| Scott, JR | 2 |
| Arakawa, M | 1 |
| Honda, K | 1 |
| Imai, T | 1 |
| Kurabayashi, T | 1 |
| Katano, K | 2 |
| Ogasawara, M | 2 |
| Suzumori, K | 2 |
| Johns, KR | 1 |
| Littlejohn, GO | 1 |
| Sasa, H | 1 |
| Sher, G | 1 |
| Matzner, W | 1 |
| Feinman, M | 1 |
| Maassarani, G | 1 |
| Zouves, C | 1 |
| Chong, P | 1 |
| Ching, W | 1 |
| Ware Branch, D | 1 |
| Hatasaka, HH | 1 |
| Leinonen, PJ | 1 |
| Li, DJ | 1 |
| Li, CJ | 1 |
| Zhu, Y | 1 |
| Cadavid, A | 1 |
| Peña, B | 1 |
| García, G | 1 |
| Botero, J | 1 |
| Sánchez, F | 1 |
| Ossa, J | 1 |
| Beer, A | 1 |
| Costa, M | 1 |
| Rossi, E | 1 |
| Backos, M | 2 |
| Baxter, N | 2 |
| Chilcott, IT | 1 |
| Reznikoff-Etievant, MF | 1 |
| Cayol, V | 1 |
| Zou, GM | 1 |
| Abuaf, N | 1 |
| Robert, A | 1 |
| Milliez, J | 1 |
| Julkunen, H | 1 |
| Jouhikainen, T | 1 |
| Kaaja, R | 1 |
| Younis, JS | 2 |
| Ohel, G | 1 |
| Haddad, S | 1 |
| Lanir, N | 1 |
| Ben-Ami, M | 1 |
| Hoffman, R | 1 |
| Blumenfeld, Z | 1 |
| Weiner, Z | 1 |
| Lê Thi Huong, D | 1 |
| Chilcott, I | 1 |
| Bar, J | 1 |
| Mashiah, R | 1 |
| Cohen-Sacher, B | 1 |
| Hod, M | 1 |
| Orvieto, R | 1 |
| Ben-Rafael, Z | 1 |
| Lahav, J | 1 |
| Valensise, H | 1 |
| Menghini, S | 1 |
| Di Pierro, G | 1 |
| Cesa, F | 1 |
| Romanini, C | 1 |
| Vinatier, D | 1 |
| Dufour, P | 1 |
| Cosson, M | 1 |
| Houpeau, JL | 1 |
| Craig, JC | 1 |
| Balducchi, JP | 1 |
| Quéré, I | 1 |
| Hoffet, M | 1 |
| Marès, P | 1 |
| Stone, S | 1 |
| Langford, K | 1 |
| Nelson-Piercy, C | 1 |
| Bewley, S | 1 |
| Hunt, BJ | 1 |
| Ozturk, O | 1 |
| Templeton, A | 1 |
| Diejomaoh, MF | 1 |
| Al-Azemi, MM | 1 |
| Bandar, A | 1 |
| Egbase, PE | 1 |
| Jirous, J | 1 |
| Al-Othman, S | 1 |
| Bukhadour, N | 1 |
| Al-Sweih, N | 1 |
| Birdsall, M | 1 |
| Pattison, N | 1 |
| Chamley, L | 1 |
| Passaleva, A | 1 |
| Massai, G | 1 |
| D'Elios, MM | 1 |
| Livi, C | 1 |
| Abbate, R | 1 |
| Sedano, M | 1 |
| Palma, S | 1 |
| González, P | 1 |
| Neira, O | 1 |
| Abumohor, P | 1 |
| Cerda, C | 1 |
| Guzmán, L | 1 |
| Ho, HN | 2 |
| Melinda, S | 1 |
| Lin, HH | 1 |
| Hwang, JL | 2 |
| Hsieh, CY | 2 |
| Lee, TY | 1 |
| Yoshida, A | 2 |
| Morozumi, K | 2 |
| Koyama, K | 1 |
| Fukuda, M | 1 |
| Oikawa, T | 1 |
| Hasegawa, I | 1 |
| Goto, S | 1 |
| Yamada, K | 1 |
| Sekizuka, N | 1 |
| Kanazawa, K | 1 |
| Jové, I | 1 |
| Casals, FJ | 1 |
| Ordi, J | 1 |
| Barquinero, J | 1 |
| Vilardell, M | 1 |
| Jordana, R | 1 |
| Tolosa, C | 1 |
| Selva, A | 1 |
| Genover, E | 1 |
| Huang, LW | 1 |
| Shen, MC | 1 |
| Wapner, RJ | 1 |
| Cowchock, FS | 1 |
| Shapiro, SS | 1 |
| Gancel, A | 1 |
| Courtois, H | 1 |
| Doucet, J | 1 |
| Schrub, JC | 1 |
| Le Bouedec, G | 1 |
| Fondrinier, E | 1 |
| Sauvezie, B | 1 |
| Bruhat, MA | 1 |
| Suganuma, T | 1 |
| Shinmura, I | 1 |
| Fujinami, T | 1 |
| Yagami, Y | 1 |
| Andersen, ES | 1 |
| Grunnet, N | 1 |
| Parke, A | 1 |
| Maier, D | 1 |
| Hakim, C | 1 |
| Randolph, J | 1 |
| Andreoli, J | 1 |
| Falconer, J | 1 |
| Pineo, G | 1 |
| Blahey, W | 1 |
| Bowen, T | 1 |
| Docksteader, B | 1 |
| Jadusingh, I | 1 |
| Snethlage, W | 1 |
| Ten Cate, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome[NCT02303171] | Phase 4 | 100 participants (Anticipated) | Interventional | 2014-11-30 | Recruiting | ||
| Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS[NCT00180778] | Phase 1/Phase 2 | 90 participants (Anticipated) | Interventional | 2005-10-31 | Not yet recruiting | ||
| Low-molecular-weight Heparin Versus Unfractionated Heparin in Pregnant Women With History of Recurrent Abortion Secondary to Antiphospholipid Syndrome. A Randomized Controlled Trial[NCT01051778] | Phase 2 | 60 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| A Randomized Controlled Trial Comparing Low Molecular Weight Heparin and Aspirin to Aspirin Alone in Women With Unexplained Recurrent Pregnancy Loss[NCT00564174] | 88 participants (Actual) | Interventional | 2000-03-31 | Terminated (stopped due to interim analysis found no difference in LB rate and lower than expected event rate) | |||
| A Pilot Study Assessing the Feasibility of a Randomized Controlled Trial Evaluating Aspirin Versus Low-molecular-weight Heparin (LMWH) and Aspirin in Women With Antiphospholipid Syndrome and Pregnancy Loss[NCT03100123] | Early Phase 1 | 1 participants (Actual) | Interventional | 2017-11-06 | Terminated (stopped due to Pilot deemed not feasible by Steering Committee due to recruitment rate.) | ||
| Role of LMWH (Enoxaparine) With or Without Aspirin in the Prevention of Habitual Abortion; Special Attention to the Thrombophilic Status of the Mother[NCT00959621] | Phase 3 | 220 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin[NCT02144064] | Phase 3 | 200 participants (Anticipated) | Interventional | 2019-06-23 | Recruiting | ||
| A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)[NCT01661439] | 316 participants (Anticipated) | Observational | 2012-03-31 | Recruiting | |||
| Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage[NCT01917799] | Phase 4 | 150 participants (Anticipated) | Interventional | 2009-01-31 | Recruiting | ||
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174] | 420 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss ,Double Blinded Randomized Controlled Trial .[NCT05237843] | Phase 1 | 70 participants (Anticipated) | Interventional | 2022-03-01 | Not yet recruiting | ||
| Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension: A Pilot Study[NCT04908982] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-05-28 | Recruiting | ||
| Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE): a Randomized Controlled Trial[NCT05253781] | Phase 3 | 476 participants (Anticipated) | Interventional | 2020-07-01 | Recruiting | ||
| A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome[NCT04624269] | Phase 4 | 384 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Effects of Aspirin and Intrauterine Balloon on the Post-operative Uterine Endometrial Repair and Reproductive Prognosis in Patients With Severe Intrauterine Adhesion: a Prospective Cohort Study[NCT02744716] | 114 participants (Actual) | Interventional | 2011-05-31 | Completed | |||
| Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses[NCT01828697] | Phase 4 | 1,110 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| Evaluation of the Benefit of Adjuvant Treatment With Hydroxychloroquine to the Usual Medical Management for Obtaining an Uncomplicated Term Pregnancy in Primary Obstetric Antiphospholipid Syndrome[NCT04275778] | Phase 2 | 110 participants (Anticipated) | Interventional | 2021-07-09 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Live birth occurs when a fetus (> 24 weeks ) , exits the maternal body and subsequently shows signs of life, such as voluntary movement, heartbeat, or pulsation of the umbilical cord. (NCT01051778)
Timeframe: pregnancy > 24weeks gestation
| Intervention | Percentage of pregnancies (Number) |
|---|---|
| Enoxaparin 40 mg /Day Plus Low Dose Aspirin | 24 |
| Heparin Calcium 5,000 U Twice Daily Plus Low Dose Aspirin | 20 |
Proportion of eligible subjects who provide consent. (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Consented Eligible Patients | 1 |
Crossover rate between standard of care and experimental study arms. (NCT03100123)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Crossover Rate | 0 |
Proportion of screened patients who meet eligibility criteria (i.e. patients who meet inclusion criteria and are also eligible based on exclusion criteria). (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Screened Patients Who Met Eligibility Criteria | 4 |
Proportion of sites requiring >18 months to obtain all required approvals/contracts from time of delivery of all study documents. (NCT03100123)
Timeframe: 18 months
| Intervention | Sites (Number) |
|---|---|
| Approval Timeline | 1 |
Level of compliance with study drug through patient recall and patient medication diary. (NCT03100123)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Standard of Care Arm | 0 |
| Experimental Arm | 1 |
The primary feasibility outcome of the pilot trial is the mean recruitment rate per center per month. (NCT03100123)
Timeframe: 24 months
| Intervention | participants (Number) |
|---|---|
| Experimental Arm | 1 |
Proportion of withdrawals/loss to follow-up among randomized patients. (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Withdrawal/Lost to Follow-up | 0 |
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 7 |
| Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 374 |
| Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 28 |
| Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 3 |
| Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 4 |
| Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 394 |
| Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
| Intervention | livebirths (Number) |
|---|---|
| Aspirin | 309 |
| Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 0 |
| Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 32 |
| Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 56 |
| Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
| Intervention | infants (Number) |
|---|---|
| Aspirin | 22 |
| Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
| Intervention | grams (Mean) |
|---|---|
| Aspirin | 3327 |
| Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
| Intervention | participants (Number) |
|---|---|
| Aspirin | 2 |
| Placebo | 2 |
68 reviews available for aspirin and Abortion, Recurrent
| Article | Year |
|---|---|
Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Female; Heparin; Heparin, | 2022 |
Low-dose aspirin for the prevention of preterm birth: More questions than answers.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Infant, Newbor | 2022 |
Impact of subchorionic hematoma on pregnancy outcomes in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Aspirin; Female; Hematoma; Humans; Pregnancy; Pregnancy Complications; Pregnancy | 2023 |
Interventions to prevent miscarriage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; Female; Heparin; Humans; Hypothyroidism; Pregnan | 2023 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gestational Age | 2020 |
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin, | 2021 |
Inherited thrombophilia and anticoagulant therapy for women with reproductive failure.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Blood Coagulation; Female; Heparin; Humans; Infertility | 2021 |
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Aspirin; Combined Modality Therapy; Femal | 2021 |
Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2021 |
Current insights in obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2017 |
Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid | 2019 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2018 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Live Birth; Pre-Eclampsia; | 2019 |
Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2013 |
Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspir | 2013 |
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retarda | 2014 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome].
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2013 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrin | 2014 |
Antiphospholipid antibody syndrome and reproduction.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans | 2014 |
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin, | 2014 |
Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Birth Weight; Female; Gestational Age; Heparin, Low-Mol | 2016 |
Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
Topics: Abortion, Habitual; Adalimumab; Aspirin; Embryo Implantation; Etanercept; Female; Heparin; Humans; I | 2016 |
Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Female; Heparin; Humans; Pregnancy; Publication Bias | 2016 |
[The management of pregnant women with antiphospholipid syndrome].
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; | 2007 |
[Inherited thrombophilia in women with recurrent miscarriages and pregnancy loss in anamnesis--own experience].
Topics: Abortion, Habitual; Adult; Aspirin; Factor V; Female; Fibrinolytic Agents; Heparin, Low-Molecular-We | 2008 |
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecul | 2009 |
Recurrent miscarriage.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Hep | 2008 |
Aspirin in recurrent miscarriage: is there an indication?
Topics: Abortion, Habitual; Aspirin; Contraindications; Cyclooxygenase Inhibitors; Female; Humans; Pregnancy | 2009 |
Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2010 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Blood Transfus | 2009 |
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fibrinoly | 2010 |
[Progress of integrative medical treatment of recurrent natural abortion induced by immune factor].
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Drug Therapy, Combination; Drugs, Chinese | 2010 |
Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Dr | 2011 |
Recurrent miscarriage.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Hep | 2011 |
Obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Antibody-Dependent Cell Cytotoxicity; Ant | 2012 |
Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Hepari | 2011 |
Testing for inherited thrombophilia in recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Preg | 2011 |
Recurrent miscarriage and thrombophilia: an update.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Evidence-Based Medicine; Fem | 2012 |
[Medical treatment for recurrent miscarriages].
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulant | 2002 |
Low molecular weight heparin in immunological recurrent abortion--the incredible cure.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 2003 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Annexin A5; Antibodies, Anticardiolipin; Anticoagu | 2003 |
Treatment of pregnancy loss in Hughes syndrome: a critical update.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Heparin; H | 2002 |
[Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
Topics: Abortion, Habitual; Adrenal Cortex Hormones; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Hu | 2003 |
Recurrent spontaneous early pregnancy loss and low dose aspirin.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Humans; Pl | 2003 |
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Ev | 2004 |
The management of pregnant patients with antiphospholipid syndrome.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pla | 2004 |
Immunologic manipulation for the threatened fetus.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; B-Lymphocytes; Complement C1 Inactivator Pro | 2004 |
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; Fibrin | 2005 |
Obstetrical antiphospholipid syndrome.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Fem | 2006 |
The obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Heparin | 2008 |
Non-surgical interventions for threatened and recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Threatened; Antiphospholipid Syndrome; Aspirin; Bed Rest; Chorionic Go | 2007 |
Antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2008 |
Understanding prostaglandin metabolites and platelet-activating factor in the pathophysiology and treatment of the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Humans; Platelet Activating Factor; | 1995 |
Current status of immunologic recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antilymphocyte Serum; Aspirin; Autoimmune Diseases | 1993 |
Aspirin in essential thrombocythemia: status quo and quo vadis.
Topics: Abortion, Habitual; Aspirin; Cerebrovascular Disorders; Cohort Studies; Contraindications; Erythrome | 1997 |
The antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Huma | 1998 |
Antiphospholipid antibodies and infertility: fact or fallacy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antip | 1998 |
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1998 |
Antiphospholipid syndrome and pregnancy loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 1998 |
[Phospholipid antigens, thrombosis and repeated fetal death].
Topics: Abortion, Habitual; Adult; Antigens; Aspirin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; | 1996 |
[Antiphospholipid antibody syndrome in adverse pregnancy].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; A | 2000 |
[Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2000 |
Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Blood Platelet Disorders; Coagulation | 2000 |
Antiphospholipid syndrome and recurrent miscarriages.
Topics: Abortion, Habitual; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Antibodies, Antiphospholip | 2001 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2002 |
Aspirin dilemma. Remodelling the hypothesis from a fertility perspective.
Topics: Abortion, Habitual; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Admin | 2002 |
Autoimmune factors in assisted reproduction.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Ant | 2002 |
50 trials available for aspirin and Abortion, Recurrent
| Article | Year |
|---|---|
Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fi | 2019 |
Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Administration Schedule; Drug Therapy, Comb | 2020 |
Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
Topics: Abortion, Habitual; Adult; Aspirin; Biomarkers; Female; Heparin, Low-Molecular-Weight; Humans; Immun | 2021 |
Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combina | 2017 |
Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial.
Topics: Abortion, Habitual; Adult; Aspirin; Double-Blind Method; Drug Administration Schedule; Female; Follo | 2018 |
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Aspirin; Birth Weight; Embryo Implantation; Enoxaparin; Female; Fibrinoly | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Egypt; Eno | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Middle A | 2018 |
Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity in women with recurrent miscarriage due to impaired uterine perfusion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Arteries; Aspirin; Blood Flow Velocity; Cyclooxyge | 2009 |
Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Resp | 2009 |
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Topics: Abortion, Habitual; Adult; Antibodies, Antinuclear; Anticoagulants; Antiphospholipid Syndrome; Aspir | 2009 |
Use of heparin in women with early and late miscarriages with and without thrombophilia.
Topics: Abortion, Habitual; Adult; Age Factors; Aspirin; Biomarkers; Case-Control Studies; Dalteparin; Drug | 2009 |
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Infant, Newborn; Pla | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2007 |
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Earl | 2011 |
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2011 |
Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Embryo Loss; Female; Heparin, Low-Mol | 2012 |
Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Cohort Studies; Dr | 2002 |
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Ther | 2003 |
Prevalence of anticardiolipin antibody IgG in recurrent first trimester abortions and the role of aspirin in its prevention.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Aspirin; F | 2003 |
[Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; A | 2003 |
[Effect of intravenous gamma-globulin therapy on lymphocyte population in pregnant women with antiphospholipid antibodies].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; beta | 2004 |
Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Drug Therapy, Comb | 2005 |
Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Docosahexaenoic Acids; Dose-Response | 2005 |
Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2005 |
Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Topics: Abortion, Habitual; Activins; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Case-Contro | 2006 |
The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Anticoagulants; Apgar Score; Aspirin; Birth | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Induced; Adult; Anticoagulants; Aspirin; Birth Rate; Birth Weight; Eno | 2006 |
Thrombophilia and antithrombotic therapy in women with recurrent spontaneous abortions.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Factors; Female; Fibrinolytic Agents; Greece; | 2007 |
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Huma | 2007 |
Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Enoxaparin; | 2008 |
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antibodies | 2008 |
[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy].
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 1995 |
A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Dose-Response Relationship, Immuno | 1996 |
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1997 |
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; He | 1996 |
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production.
Topics: Abortion, Habitual; Adult; Aspirin; Autoimmune Diseases; Blood Platelets; Epoprostenol; Female; Huma | 1997 |
The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Case-Control Studies; Drug Therapy, C | 1998 |
Heparin plus aspirin as a "single" therapy for recurrent spontaneous abortion associated with both allo- and autoimmunity.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Autoantibodies; Female; Heparin; Humans; Immunot | 1999 |
Antiphospholipid antibodies and pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Birth Rate; Female; Fetal | 1999 |
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Dru | 1999 |
Recurrent miscarriage--an aspirin a day?
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Birth Rate; | 2000 |
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Immunoglobulins, I | 2001 |
Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Resistance; Enoxaparin; | 2002 |
Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody.
Topics: Abortion, Habitual; Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; Drug Evalua | 1992 |
118 other studies available for aspirin and Abortion, Recurrent
| Article | Year |
|---|---|
Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Topics: Abortion, Habitual; Adolescent; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Female; Fe | 2021 |
Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.
Topics: Abortion, Habitual; Adult; Animals; Aspirin; Biomarkers; Decidua; Disease Management; Disease Models | 2021 |
Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
Topics: Abortion, Habitual; Aspirin; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infant, | 2022 |
A retrospective study on IVF/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2022 |
Analysis of the guidance and predictive value of uterine artery flow parameters in patients with recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Retrospective | 2023 |
Recurrent MiscarriageGreen-top Guideline No. 17.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Male; Pregnancy; Pr | 2023 |
Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Autophagy; Cell Movement; Cell Proliferation; Female; Humans; MicroRNAs | 2024 |
Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: A cohort study.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; China; Drug Therapy, Combination; Female; | 2020 |
Uterine Radial Artery Resistance Index Predicts Reproductive Outcome in Women with Recurrent Pregnancy Losses and Thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Live Bir | 2019 |
D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrin | 2020 |
Destruction in maternal-fetal interface of URSA patients via the increase of the HMGB1-RAGE/TLR2/TLR4-NF-κB signaling pathway.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antigens, Neoplasm; Aspirin; Female; Fetus; Gene Expressi | 2020 |
Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; China; Endometrium; Female; Humans; Pregna | 2020 |
Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages?
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Dietary Supplements; Female; Folic Acid; Humans; | 2020 |
Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Antinuclear; Aspirin; Female; Humans; Infant, Newborn; Prednisone; P | 2021 |
Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study.
Topics: Abortion, Habitual; Adult; Arachidonic Acid; Aspirin; Case-Control Studies; Female; Humans; Platelet | 2022 |
Pregnancy in patients with myelofibrosis: Mayo-Florence series of 24 pregnancies in 16 women.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Diabetes, Gestational; Female; Fetal Death; Hemo | 2021 |
Effects of aspirin, vitamin D3, and progesterone on pregnancy outcomes in an autoimmune recurrent spontaneous abortion model.
Topics: Abortion, Habitual; Animals; Aspirin; Cholecalciferol; Female; Humans; Mice; Placenta; Pregnancy; Pr | 2021 |
Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss.
Topics: Abortion, Habitual; Aspirin; China; Endometrium; Female; Humans; Perfusion; Pregnancy; Retrospective | 2022 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Daltepar | 2017 |
Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Endometrium; E | 2018 |
Treatment for patients with recurrent fetal losses positive for anti-cardiolipin beta2 glycoprotein I antibody using Sairei-to (Chai-ling-tang) and low-dose aspirin.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; beta 2-Glycoprotein I; Cardiolipins; Drug Therap | 2019 |
[Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 2018 |
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort | 2019 |
Antagonists of TNFα for recurrent miscarriages: 2 Illustrative cases.
Topics: Abortion, Habitual; Adalimumab; Adult; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; | 2019 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: a meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Pregnancy; Prospective Stud | 2019 |
Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage.
Topics: Abortion, Habitual; Administration, Oral; Adult; Anaphylaxis; Aspirin; Desensitization, Immunologic; | 2012 |
Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Heparin, Low- | 2013 |
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Vi | 2015 |
Successful pregnancy outcome with comprehensive treatment after 13 consecutive pregnancy losses.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Hu | 2014 |
Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Topics: Abortion, Habitual; Anticoagulants; Apgar Score; Aspirin; Birth Weight; Blood Coagulation Factors; D | 2015 |
Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Case-Control Studies; Cesarean Section; Female; | 2015 |
Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Case-Control Studies; Cell-Derived Microparticle | 2015 |
Prothrombotic state of patients with unexplained recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Aspirin; China; Female; Fibrin Fibrinogen Degradation Products; Fibrinoly | 2015 |
Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Birth Weight; Comorbidity; Drug Th | 2016 |
The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; Drug Therapy, Combination; Female; Fibrino | 2016 |
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2017 |
[Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?]
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; | 2017 |
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; beta-Thalassemia; Birth Weight; Cesarean Section | 2017 |
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Fem | 2008 |
Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants | 2008 |
A critical assessment of the role of antiphospholipid antibodies in infertility.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Drug T | 2009 |
[Recurrent spontaneous abortion--is heparin expendable to recurrence prophylaxis?].
Topics: Abortion, Habitual; Adult; Antibodies, Antinuclear; Anticoagulants; Antiphospholipid Syndrome; Aspir | 2009 |
Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relatio | 2009 |
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Female; Gestati | 2010 |
Antithrombotic therapy for recurrent miscarriage?
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Humans; Nadroparin; | 2010 |
Autoimmunity: effectiveness of treatments for pregnant women with APS.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Autoimmunity; Dose-Re | 2010 |
Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; An | 2010 |
Antithrombotic medications and recurrent miscarriage.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Bias; Double-Blind Method; Female; Heparin, Low-Molecul | 2010 |
Antithrombotic medications and recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; M | 2010 |
Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2010 |
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 2010 |
LMWH have no place in recurrent pregnancy loss: debate-against the motion.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Embryo Loss; Female; Fetus; Heparin, Low-Molecular-Weig | 2011 |
Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Comorbi | 2012 |
Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Diabetes, Gestational; Female | 2012 |
Protein A immunoadsorption in a pregnant woman with habitual abortion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; An | 2002 |
Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cohort Studies; Drug Administration Schedule; Fe | 2002 |
Live birth rate varies with gestational history and etiology in women experiencing recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Chromosome Aberrations; Corpus Luteum; Female; Humans; Immunoglobulins, | 2003 |
[Successful pregnancy outcome in the woman with thrombophilia and multiple miscarriages].
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cesarean Section; Factor V; Female; Heterozygote | 2003 |
Effect of sairei-to combined with aspirin and prednisolone on four recurrent reproductive failure women who are positive for anti-phospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Drugs, | 2003 |
Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Folic Acid; Heparin, Low-M | 2004 |
Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; Hepari | 2004 |
Antiphospholipid antibodies: a major advance in the management of recurrent abortion.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Hepari | 2004 |
Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2004 |
Prescribing for thrombophilia--are we going to repeat mistakes of the past?
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2004 |
Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.
Topics: Abortion, Habitual; Anticoagulants; Apoptosis; Aspirin; Cell Line; Dose-Response Relationship, Drug; | 2005 |
Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Drug Therapy, Combination; Female; Gestational Age; | 2005 |
Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Stu | 2006 |
[Recurrent miscarriage and thrombophilia].
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight | 2006 |
The natural course of women with recurrent fetal loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enoxaparin; Female; Fibrinolyt | 2006 |
Matching and the assumptions of standard frequentist statistics.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
[Low dose of aspirin during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Abortion, Spontaneous; Adult; Animals; Anti-Inflamm | 2007 |
Matched designs--intuitively attractive, but the analysis can be problematic.
Topics: Abortion, Habitual; Adult; Aspirin; Drug Therapy, Combination; Female; Folic Acid; Humans; Matched-P | 2007 |
Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Ant | 2008 |
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 2008 |
Clinical significance of anti-GM3 antibodies in recurrent pregnancy loss with elevated level of antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; | 1995 |
Antiphospholipid antibodies and pregnancy wastage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 1994 |
Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Down-Regulation; Female; Heparin; Humans; | 1994 |
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.
Topics: Abortion, Habitual; Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy | 1993 |
Pregnancy outcome in women with antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Immune System Dise | 1993 |
[Investigation of the association between autoantibodies and recurrent abortions].
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Autoantibodies; Female; Humans; Prednisone | 1993 |
Lupus anticoagulant. Significance in habitual first-trimester abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Lupus Coa | 1993 |
Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Blood Flow Velocity; Ductus Arteriosus; Fe | 1993 |
Low-dose aspirin and recurrent miscarriage.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Humans; | 1995 |
Placental thrombosis and second trimester miscarriage in association with activated protein C resistance.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Disorders; Factor Xa; Female; Humans; Placenta | 1996 |
Antiphospholipid (Hughes') syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans | 1997 |
Antiphospholipid antibodies, infertility and recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combina | 1997 |
Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1997 |
Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1997 |
[Abortions caused by anticardiolipin antibodies: prevention by low-dose acetylsalicylic acid].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Autoimmu | 1997 |
Prednisone and aspirin in women with recurrent fetal loss.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Female; Glucocorticoids; Humans; Prednisone; Pregnancy; | 1997 |
Hypothesis: antiphospholipid antibodies associated with congenital anomalies?
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Congeni | 1997 |
Immunosuppressive therapy for recurrent aborters with positive antiphospholipid antibodies and alteration of 6ketoPGF1 alpha/TXB2 ratio.
Topics: 6-Ketoprostaglandin F1 alpha; Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug | 1997 |
Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 1998 |
Recurrent abortion and moderate or strong antiphospholipid antibody production.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1998 |
Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
Topics: Abortion, Habitual; Adult; Aspirin; Busulfan; Female; Humans; Platelet Aggregation Inhibitors; Pregn | 1998 |
[Treatment of integrated traditional and Western medicine in recurrent spontaneous abortion of immune abnormality type].
Topics: ABO Blood-Group System; Abortion, Habitual; Adult; Aspirin; Autoantibodies; Drug Therapy, Combinatio | 1997 |
Habitual abortions in 678 healthy patients: investigation and prevention.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1999 |
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; | 2000 |
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Topics: 3' Untranslated Regions; Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; | 2000 |
Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.
Topics: Abortion, Habitual; Aspirin; Female; Fetal Growth Retardation; Fetus; Heparin, Low-Molecular-Weight; | 2001 |
Antiphospholipid antibodies do not a syndrome make.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Diagnos | 2002 |
A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; He | 2002 |
Antiphospholipid antibodies in pregnancy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Female; Humans; Lupus Coagulation Inhibito | 1992 |
Prevention of miscarriage in antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1992 |
[Recurrent loss of pregnancy in patients with anticardiolipin antibodies (ACAb)].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Aspirin; Drug Therapy, Combination; Female; | 1992 |
Treatment and outcome of unexplained recurrent spontaneous abortions in subclinical autoimmune disorders.
Topics: Abortion, Habitual; Antibodies, Antinuclear; Aspirin; Autoimmune Diseases; Female; Humans; Infant, N | 1992 |
[Prednisolone and aspirin therapy for habitual abortion associated with anti-cardiolipin antibody].
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Cardiolipins; Drug Th | 1992 |
Antiphospholipid antibodies in unselected patients with repeated abortion.
Topics: Abortion, Habitual; Adult; Antibodies; Aspirin; Autoimmunity; Blood Coagulation Factors; Female; Hum | 1990 |
Fetal loss treatment in patients with antiphospholipid antibodies.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Humans; Lupus Coagul | 1989 |
Recurrent fetal loss with circulating lupus anticoagulant: report of 2 cases.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Factors; Drug Therapy, Combination; Female; Hu | 1989 |
Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions.
Topics: Abortion, Habitual; Adult; Antibodies; Aspirin; Female; Heparin; Humans; Immunization, Passive; Infu | 1989 |
[Multiple fetal losses caused by a circulating anticoagulant. Correction with a combination of aspirin and corticotherapy].
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation; Female; Humans; Immunoglobulins; Prednisolone | 1986 |
[Full term pregnancy and Soulier-Boffa syndrome].
Topics: Abortion, Habitual; Adult; Aspirin; Autoimmune Diseases; Drug Therapy, Combination; Female; Humans; | 1988 |
[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Drug Therapy, Combination; | 1988 |
Treatment of habitual abortions associated with autoimmune abnormalities. A report of two cases.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Female; Heparin; Humans; Pr | 1988 |
Subclinical autoimmune disease and recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cardiolipins; Cesarean Sect | 1986 |
Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Fetal Growth Retardation; Humans; Platelet | 1987 |
Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment. Case report.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Humans; Pregnancy; Pregnancy Trimester, Se | 1986 |